Pay in 4 interest-free payments of $5.43 Learn more
Ships within 48 hours · Estimated delivery Aug 10 - Aug 15
Ultimately, advocating for ones health by understanding insurance policies and actively engaging with healthcare providers can lead to significant benefits
Clinical evidence of the effect of GLP-1RAs on skeletal muscle mass Clinical effects of GLP-1RAs on body composition and lean body mass Multiple clinical studies have confirmed that glucagon-like peptide-1 receptor agonists have significant effects in reducing overall weight and fat mass
Wegovy (semaglutide) is approved to reduce the risk of serious heart problems in adults with obesity or overweight who have established heart disease
Common Side Effects Nausea (most common, peaks during dose escalation) Diarrhea, constipation, vomiting Decreased appetite, fatigue, headache Injection-site reactions (injectable forms) Rare: pancreatitis, gallbladder disease, kidney injury FDA boxed warning for medullary thyroid carcinoma (do not use with personal or family history of MTC or MEN2) How to Start GLP-1 Treatment See a clinician in-person primary care, endocrinology, obesity medicine, or US telehealth
For anyone ready to act on their health now, an approved, medically supervised option is the responsible path and its one we can start with you
Each compounded prescription is prepared individually based on the specific patient's prescription parameters
